The second stakeholder dialogue shared first learnings from the Kenya launch, and to continue the discussion on how to address the burden of NCDs in lower-income countries.
An editorial for the World Economic Forum by Harald Nusser, Head Novartis Access & Malaria Initiative
Novartis is partnering with the International Committee of the Red Cross (ICRC) to improve care and treatment for Syrian refugees in Lebanon suffering from chronic diseases.
Healthcare expert Dr. Jonathan D. Quick discusses solutions to address the rapid rise of chronic illnesses in the developing world
The arrival of the first consignment of affordable Novartis Access medicines in Kenya at Mission for Essential Drugs and Supplies (MEDS) heralds a drastic reduction in the cost of treatment.
Efforts are underway to reinforce health education and healthcare delivery in rural Vietnam to combat a rise in chronic diseases such as diabetes, hypertension and respiratory ailments.
Chronic diseases kill 38 million people per year worldwide; almost three-quarters of those deaths occur in low- and middle-income countries. It’s time to act.
Chronic diseases like cancer and diabetes were once the preserve of wealthy countries but are now increasingly common in lower-income countries too as populations age and lifestyles change.
Novartis collaborates with others to help address some of the world’s greatest health challenges. Our corporate responsibility programs help more people secure the healthcare they need, regardless of where they live.
Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society report.
This site is intended for a global audience.